Works matching IS 21522650 AND DT 2025 AND VI 25 AND IP 2

Results: 13

Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e120, doi. 10.1016/j.clml.2024.09.010

By:

Khare, Somya;
Williamson, Staci;
O'Barr, Brittany;
Schachter, Levanto;
Chen, Andy;
Hayes-Lattin, Brandon;
Leonard, Jessica;
Desai, Amrita;
Ferreira-Gandolfo, Peter;
Christmas, Kevin;
Lackey, Denise;
Maziarz, Richard T;
Nemecek, Eneida R.

Publication type:

Article

Real World Outcome of High-Risk Multiple Myeloma: An Indian Tertiary Care Centre Experience.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e110, doi. 10.1016/j.clml.2024.09.007

By:

Soni, Anveshika;
Rainchwar, Sujay;
Singh, Reema;
Gupta, Dikshat Gopal;
Tikare, Nakul;
Halder, Rohan;
Palatty, Roy J.;
Sheth, Vipul Sharad;
Agrawal, Narendra;
Bhurani, Dinesh;
Panda, Tribikram

Publication type:

Article

Real-Life Management of Patients Aged 80 Years Old and Over With Multiple Myeloma: Results of the EMMY Cohort.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e103, doi. 10.1016/j.clml.2024.09.006

By:

Chalopin, T.;
Macro, M.;
Decaux, O.;
Royer, B.;
Gounot, R.;
Bobin, A.;
Karlin, L.;
Mohty, M.;
Frenzel, L.;
Perrot, A.;
Manier, S.;
Vincent, L.;
Dib, M.;
Slama, B.;
Richez, V.;
Allangba, O.;
Zunic, P.;
Newinger-Porte, M.;
Mariette, C.;
Joly, B.

Publication type:

Article

Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e96, doi. 10.1016/j.clml.2024.09.005

By:

Straining, Rachael;
Foss, Francine;
Schiffer, Molly;
Amin, Kejal;
Agarwal, Sonal;
Isufi, Iris;
Huntington, Scott;
Kothari, Shalin;
Seropian, Stuart;
Girardi, Michael;
Sethi, Tarsheen

Publication type:

Article

Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e90, doi. 10.1016/j.clml.2024.09.003

By:

Lin, Andrew;
Pearl, Nicole;
Flynn, Jessica;
Devlin, Sean;
Dahi, Parastoo;
Perales, Miguel-Angel;
Scordo, Michael;
Shah, Gunjan L.

Publication type:

Article

SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 77, doi. 10.1016/j.clml.2024.05.018

By:

Shmidt, Daniil;
Mamonkin, Maksim

Publication type:

Article

Impact of Gut Microbiota on Lymphoma: New Frontiers in Cancer Research.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e82, doi. 10.1016/j.clml.2024.08.008

By:

Sanabani, Sabri Saeed

Publication type:

Article

Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 124, doi. 10.1016/j.clml.2024.08.003

By:

Jing Christine Ye;
Biran, Noa;
Nair, Sandhya;
Xiwu Lin;
Keqin Qi;
Londhe, Anil;
Ammann, Eric;
Renaud, Thomas;
Kane, Colleen;
Parekh, Trilok;
Gray, Kathleen;
Peterson, Steve;
Costa, Luciano J.

Publication type:

Article

The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 96, doi. 10.1016/j.clml.2024.08.004

By:

Chakrabarti, Ritu;
Siegel, David;
Biran, Noa

Publication type:

Article

Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 109, doi. 10.1016/j.clml.2024.07.017

By:

Fiala, Mark A.;
Mengmeng Ji;
Yi-Hsuan Shih;
Huber, John;
Mei Wang;
Johnson, Kimberly J.;
Gasoyan, Hamlet;
Rong Wang;
Colditz, Graham A.;
Shi-Yi Wang;
Su-Hsin Chang

Publication type:

Article

VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG).

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. e71, doi. 10.1016/j.clml.2024.08.007

By:

Kastritis, Efstathios;
Beksac, Meral;
Badelita, Sorina Nicoleta;
Katodritou, Eirini;
Bila, Jelena;
Spanoudakis, Emmanouil;
Seval, Guldane Cengiz;
Cvetkovic, Zorica;
Markovic, Olivera;
Toprak, Selami Koçak;
Dalampira, Dimitra;
Coriu, Daniel;
Bezirgiannidou, Zoi;
Pirsic, Mario;
Valkovic, Toni;
Ursuleac, Iulia;
Sretenovic, Aleksandra;
Sevastoudi, Angeliki;
Batinic, Josip;
Barbu, Sinziana

Publication type:

Article

SOHO State of the Art Updates and Next Questions | Covalent Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 89, doi. 10.1016/j.clml.2024.05.019

By:

Alsouqi, Aseel;
Woyach, Jennifer A.

Publication type:

Article

Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019

By:

Okcu, Izel;
Yucai Wang;
Bock, Allison M.;
Jihao Zhou;
Moustafa, Muhamad Alhaj;
Tun, Han W.;
Rosenthal, Allison C.;
Johnston, Patrick B.;
Baidoun, Firas;
Khurana, Arushi;
Kabat, Brian F.;
King, Rebecca L.;
Habermann, Thomas M.;
Nowakowski, Grzegorz S.

Publication type:

Article